Literature DB >> 15039971

Five haplotypes account for fifty-five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: seven new mutations.

Gabriela Coutinho1, Midori Mitui, Catarina Campbell, Beatriz T Costa Carvalho, Shareef Nahas, Xia Sun, Yong Huo, Chih-Hung Lai, Yvonne Thorstenson, Robert Tanouye, Salmo Raskin, Chong A Kim, Juan Llerena, Richard A Gatti.   

Abstract

We have studied the molecular genetics of 27 Brazilian families with ataxia telangiectasia (AT). Five founder effect haplotypes accounted for 55.5% of the families. AT is an autosomal recessive disorder of childhood onset characterized by progressive cerebellar ataxia, ocular apraxia, telangiectasia, immunodeficiency, radiation sensitivity, chromosomal instability, and predisposition to cancer. The ATM gene spans more than 150 kb on chromosome region 11q23.1 and encodes a product of 3056 amino acids. The ATM protein is a member of the phosphatidylinositol 3-kinase (PI-3K) family of proteins and is involved in cell cycle control and DNA repair pathways. DNA was isolated from lymphoblastoid cell lines and haplotyped using four STR markers (D11S1818, NS22, D11S2179, D11S1819) within and flanking the ATM gene; all allele sizes were standardized in advance. In addition to the STR haplotypes, SNP haplotypes were determined using 10 critical polymorphisms. The entire gene was screened sequentially by protein truncation testing (PTT), single strand conformation polymorphism (SSCP), and then denaturing high performance liquid chromatography (dHPLC) to identify the disease-causing mutations. Of the expected 54 mutations, 50 were identified. All mutations but one, led to a truncated or null form of the ATM protein (nonsense, splice site, or frameshift). Five families (18.5%) carried a deletion of 3450nt (from IVS28 to Ex31), making this one of the two most common Brazilian mutations. Mutations were located throughout the entire gene, with no clustering or hotspots. Standardized STR haplotype analysis greatly enhanced the efficiency of mutation screening. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039971     DOI: 10.1002/ajmg.a.20570

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.

Authors:  Kotoka Nakamura; Liutao Du; Rashmi Tunuguntla; Francesca Fike; Simona Cavalieri; Tomohiro Morio; Shuki Mizutani; Alfredo Brusco; Richard A Gatti
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

2.  New mutations in the ATM gene and clinical data of 25 AT patients.

Authors:  Ilja Demuth; Véronique Dutrannoy; Wilson Marques; Heidemarie Neitzel; Detlev Schindler; Petja S Dimova; Krystyna H Chrzanowska; Veneta Bojinova; Hanna Gregorek; Luitgard M Graul-Neumann; Arpad von Moers; Ilka Schulze; Marion Nicke; Elcin Bora; Tufan Cankaya; Éva Oláh; Csongor Kiss; Beáta Bessenyei; Katalin Szakszon; Ursula Gruber-Sedlmayr; Peter Michael Kroisel; Sigrun Sodia; Timm O Goecke; Thilo Dörk; Martin Digweed; Karl Sperling; Joaquim de Sá; Charles Marques Lourenco; Raymonda Varon
Journal:  Neurogenetics       Date:  2011-10-02       Impact factor: 2.660

3.  ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.

Authors:  Mahnoush Babaei; Midori Mitui; Eric R Olson; Richard A Gatti
Journal:  Hum Genet       Date:  2005-04-21       Impact factor: 4.132

Review 4.  Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome.

Authors:  Hélio A G Teive; Adriana Moro; Mariana Moscovich; Walter O Arruda; Renato P Munhoz; Salmo Raskin; Tetsuo Ashizawa
Journal:  J Neurol Sci       Date:  2015-05-29       Impact factor: 3.181

5.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

6.  Ten new ATM alterations in Polish patients with ataxia-telangiectasia.

Authors:  Marta Joanna Podralska; Agnieszka Stembalska; Ryszard Ślęzak; Aleksandra Lewandowicz-Uszyńska; Barbara Pietrucha; Sylwia Kołtan; Jadwiga Wigowska-Sowińska; Jacek Pilch; Maria Mosor; Iwona Ziółkowska-Suchanek; Agnieszka Dzikiewicz-Krawczyk; Ryszard Słomski
Journal:  Mol Genet Genomic Med       Date:  2014-07-30       Impact factor: 2.183

7.  ATM gene mutations in sporadic breast cancer patients from Brazil.

Authors:  Flavia Rotea Mangone; Elisabete C Miracca; Harriet E Feilotter; Lois M Mulligan; Maria Aparecida Nagai
Journal:  Springerplus       Date:  2015-01-15

8.  Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil.

Authors:  Gabriela E S Felix; Rodrigo Santa Cruz Guindalini; Yonglan Zheng; Tom Walsh; Elisabeth Sveen; Taisa Manuela Machado Lopes; Juliana Côrtes; Jing Zhang; Polyanna Carôzo; Irlânia Santos; Thaís Ferreira Bonfim; Bernardo Garicochea; Maria Betânia Pereira Toralles; Roberto Meyer; Eduardo Martins Netto; Kiyoko Abe-Sandes; Mary-Claire King; Ivana Lucia de Oliveira Nascimento; Olufunmilayo I Olopade
Journal:  Breast Cancer Res Treat       Date:  2022-03-30       Impact factor: 4.624

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.